Informa Receives Sell Rating from Liberum Capital (INF)
Informa (LON:INF)‘s stock had its “sell” rating reaffirmed by analysts at Liberum Capital in a research report issued to clients and investors on Wednesday, Analyst Ratings.Net reports. They currently have a GBX 450 ($7.26) price objective on the stock. Liberum Capital’s price objective indicates a potential downside of 13.21% from the company’s current price.
INF has been the subject of a number of other recent research reports. Analysts at AlphaValue reiterated a “reduce” rating on shares of Informa (LON:INF) in a research note to investors on Thursday, September 26th. They now have a GBX 558 ($9.00) price target on the stock. Separately, analysts at Panmure Gordon reiterated a “buy” rating on shares of Informa (LON:INF) in a research note to investors on Thursday, September 26th. They now have a GBX 630 ($10.16) price target on the stock. Finally, analysts at Barclays Capital raised their price target on shares of Informa (LON:INF) from GBX 565 ($9.12) to GBX 615 ($9.92) in a research note to investors on Thursday, September 19th. They now have an “overweight” rating on the stock. Two equities research analysts have rated the stock with a sell rating, twelve have issued a hold rating and ten have issued a buy rating to the company’s stock. The company presently has an average rating of “Hold” and a consensus target price of GBX 547.60 ($8.84).
Informa (LON:INF) traded down 1.43% during mid-day trading on Wednesday, hitting GBX 518.50. The stock had a trading volume of 816,744 shares. Informa has a 52 week low of GBX 377.70 and a 52 week high of GBX 550.00. The stock has a 50-day moving average of GBX 525.1 and a 200-day moving average of GBX 509.. The company’s market cap is £3.126 billion.
Informa plc provides academics, businesses and individuals with knowledge, information and skills and services.
Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.